newsfilter
← Latest News
Business Wire·

Turn Therapeutics to Present at Upcoming TD Cowen and Oppenheimer Healthcare Conferences

  • Turn Therapeutics CEO Brad Burnam will present at the 36th Annual Oppenheimer Healthcare Life Sciences Conference on February 25, 2026, from 8:00 a.m. to 8:30 a.m. Eastern Time.
  • The company will also present at the 46th Annual TD Cowen Healthcare Conference in Boston on March 2, 2026, from 1:10 p.m. to 1:40 p.m. Eastern Time.
  • Management will provide an update on the dermatology pipeline, including the status of the Phase 2 clinical trial for lead therapy GX-03.
  • GX-03 is a first-in-class, non-systemic topical inhibitor currently in late-stage development for moderate-to-severe atopic dermatitis.
  • Executives will participate in one-on-one meetings with institutional investors during these events.
  • Live webcasts will be accessible via the investors section of the Turn Therapeutics website, with replays available for approximately 30 days.